IOL CHEMICALS & PHARM. | CONCORD DRUGS | IOL CHEMICALS & PHARM./ CONCORD DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.1 | 38.6 | 34.0% | View Chart |
P/BV | x | 1.5 | 1.2 | 123.5% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. CONCORD DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
CONCORD DRUGS Mar-23 |
IOL CHEMICALS & PHARM./ CONCORD DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 42 | 1,288.6% | |
Low | Rs | 272 | 20 | 1,395.9% | |
Sales per share (Unadj.) | Rs | 377.6 | 55.9 | 675.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 1.1 | 2,240.2% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 2.8 | 1,126.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 33.4 | 768.6% | |
Shares outstanding (eoy) | m | 58.71 | 9.32 | 629.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.5 | 195.8% | |
Avg P/E ratio | x | 17.1 | 28.9 | 59.0% | |
P/CF ratio (eoy) | x | 12.8 | 10.9 | 117.5% | |
Price / Book Value ratio | x | 1.6 | 0.9 | 172.2% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 285 | 8,336.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 38 | 4,381.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 521 | 4,257.0% | |
Other income | Rs m | 256 | 0 | 284,555.6% | |
Total revenues | Rs m | 22,427 | 521 | 4,305.6% | |
Gross profit | Rs m | 2,257 | 46 | 4,935.9% | |
Depreciation | Rs m | 462 | 16 | 2,838.9% | |
Interest | Rs m | 165 | 17 | 965.4% | |
Profit before tax | Rs m | 1,887 | 12 | 15,104.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 3 | 18,825.1% | |
Profit after tax | Rs m | 1,391 | 10 | 14,111.6% | |
Gross profit margin | % | 10.2 | 8.8 | 115.9% | |
Effective tax rate | % | 26.2 | 21.1 | 124.4% | |
Net profit margin | % | 6.3 | 1.9 | 331.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 435 | 2,224.4% | |
Current liabilities | Rs m | 5,025 | 216 | 2,324.9% | |
Net working cap to sales | % | 20.9 | 41.9 | 49.9% | |
Current ratio | x | 1.9 | 2.0 | 95.7% | |
Inventory Days | Days | 43 | 7 | 663.3% | |
Debtors Days | Days | 8 | 1,108 | 0.8% | |
Net fixed assets | Rs m | 11,017 | 148 | 7,456.8% | |
Share capital | Rs m | 587 | 93 | 630.2% | |
"Free" reserves | Rs m | 14,490 | 218 | 6,639.5% | |
Net worth | Rs m | 15,077 | 311 | 4,841.7% | |
Long term debt | Rs m | 0 | 19 | 0.0% | |
Total assets | Rs m | 20,684 | 582 | 3,552.0% | |
Interest coverage | x | 12.5 | 1.7 | 719.0% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.9 | 119.8% | |
Return on assets | % | 7.5 | 4.6 | 162.8% | |
Return on equity | % | 9.2 | 3.2 | 291.6% | |
Return on capital | % | 13.6 | 8.9 | 152.2% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 17 | 7,352.4% | |
From Investments | Rs m | -1,200 | -23 | 5,295.7% | |
From Financial Activity | Rs m | -41 | 6 | -658.7% | |
Net Cashflow | Rs m | -18 | 0 | -8,363.6% |
Indian Promoters | % | 48.2 | 55.4 | 87.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 44.6 | 116.2% | |
Shareholders | 130,003 | 4,032 | 3,224.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | CONCORD DRUGS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.44% | 3.01% | -0.60% |
1-Month | -4.75% | 3.01% | 2.00% |
1-Year | -4.34% | 27.24% | 49.59% |
3-Year CAGR | -12.08% | -1.13% | 14.15% |
5-Year CAGR | 15.29% | 10.65% | 19.16% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the CONCORD DRUGS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of CONCORD DRUGS the stake stands at 55.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of CONCORD DRUGS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
CONCORD DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of CONCORD DRUGS.
For a sector overview, read our pharmaceuticals sector report.
It was indeed a volatile trading session for Indian share markets yesterday.